HK2 and ovarian cancer: A previous study in ovarian cancer xenografts treated with Carboplatin and Paclitaxel showed a decrease in SUVmax by 4 days after treatment, which correlated with a decrease in GLUT gene expression and a significant decrease in HKI but not HKII expression [44].